arrow
返回
P

Phillip Angart

us food & drug administration (fda)

8H指数
20论文数
177被引数
收录论文 7
发表时间
err分享
err收藏
Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events
err2020-06-04
err4
errOAAI
errFratz-Berilla, Erica J.; Angart, Phillip; Graham, Ryan J.; Powers, David N.; Mohammad, Adil; Kohnhorst, Casey; Faison, Talia; Velugula-Yellela, Sai Rashmika; Trunfio, Nicholas; Agarabi, Cyrus
err分享
err收藏
The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability
err2020-02-12
err8
errOAAI
errXie, Tao; Fang, Hui; Ouyang, Weiming; Angart, Phillip; Chiang, Meng-Jung; Bhirde, Ashwinkumar A.; Sheikh, Faruk; Lynch, Patrick; Shah, Ankit B.; Patil, Sharadrao M.; Chen, Kang; Shen, Meiyu; Agarabi, Cyrus; Donnelly, Raymond P.; Brorson, Kurt; Schrieber, Sarah J.; Howard, Kristina E.; Rogstad, Sarah M.; Frucht, David M.
err分享
err收藏
Considerations for risk and control of mycoplasma in bioprocessing
err2018-12-01
err7
errOAAI
errAngart, Phillip; Kohnhorst, Casey; Chiang, Meng-Jung; Arden, Nilou Sarah
err分享
err收藏
Brain derived neurotrophic factor release from layer-by-layer coated agarose nerve guidance scaffolds
err2015-05-01
err22
PREAI
errLynam, Daniel A.; Shahriari, Dena; Wolf, Kayla J.; Angart, Phillip A.; Koffler, Jacob; Tuszynski, Mark H.; Chan, Christina; Walton, Patrick; Sakamoto, Jeffrey
err分享
err收藏